Literature DB >> 1534852

Multistep regulation of enhancer activity of the 21-base-pair element of human T-cell leukemia virus type I.

M Niki1, K Ohtani, M Nakamura, K Sugamura.   

Abstract

We examined the regulatory mechanisms of binding and transcriptional enhancement of the 21-bp core element of the enhancer of human T-cell leukemia virus type I (HTLV-I) in response to forskolin, 12-O-tetradecanoylphorbol-13-acetate (TPA), and a viral transactivator, p40tax. The 21-bp core element has been shown to bind to a cyclic AMP-responsive element binding protein (CREB)-like molecule at the site of an imperfect palindrome containing the TGAC motif. Experiments with oligonucleotides with mutations in the imperfect palindrome demonstrated that one TGAC motif is necessary and sufficient for both the binding of the CREB-related factor and transcriptional activity in response to forskolin in a human T-cell line, Jurkat. We also found that binding of the CREB-like factor to the 21-bp core element was enhanced by treatment with TPA, with little effect on transcriptional activity; in contrast, forskolin and p40tax did not facilitate binding, though they enhanced transcription. The combination of forskolin and TPA synergistically induced the transcription activity of the element, showing a hierarchical mechanism of regulation of the HTLV-I core enhancer element to levels sufficient for formation of the factor-enhancer complex and for activation of the complex. Added to those findings, our results indicate that the modes of activation by forskolin and p40tax are different from each other.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534852      PMCID: PMC241241     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene.

Authors:  A Lilienbaum; M Duc Dodon; C Alexandre; L Gazzolo; D Paulin
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

2.  Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat.

Authors:  K Nagata; K Ohtani; M Nakamura; K Sugamura
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

3.  Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP.

Authors:  H T Poteat; P Kadison; K McGuire; L Park; R E Park; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP.

Authors:  M Nakamura; M Niki; K Ohtani; K Sugamura
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

5.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence.

Authors:  G A Gonzalez; K K Yamamoto; W H Fischer; D Karr; P Menzel; W Biggs; W W Vale; M R Montminy
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

7.  Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells.

Authors:  M Sawada; A Suzumura; M Yoshida; T Marunouchi
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

8.  Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.

Authors:  S Miura; K Ohtani; N Numata; M Niki; K Ohbo; Y Ina; T Gojobori; Y Tanaka; H Tozawa; M Nakamura
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

9.  Cyclic AMP regulation of the human glycoprotein hormone alpha-subunit gene is mediated by an 18-base-pair element.

Authors:  B J Silver; J A Bokar; J B Virgin; E A Vallen; A Milsted; J H Nilson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.

Authors:  S J Kim; J H Kehrl; J Burton; C L Tendler; K T Jeang; D Danielpour; C Thevenin; K Y Kim; M B Sporn; A B Roberts
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  6 in total

1.  In vitro transcription of human T-cell leukemia virus type 1 is RNA polymerase II dependent.

Authors:  B A Lenzmeier; J K Nyborg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 2.  CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth.

Authors:  Y S Cho-Chung; Y G Park; M Nesterova; Y N Lee; Y S Cho
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region.

Authors:  X Xu; D A Brown; I Kitajima; J Bilakovics; L W Fey; M I Nerenberg
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

4.  GLI-2 modulates retroviral gene expression.

Authors:  M J Smith; S D Gitlin; C M Browning; B R Lane; N M Clark; N Shah; S Rainier; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Authors:  N M Clark; M J Smith; J M Hilfinger; D M Markovitz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element.

Authors:  K G Low; H M Chu; P M Schwartz; G M Daniels; M H Melner; M J Comb
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.